Enveric Biosciences, Inc. · NASDAQ:ENVB
Ayrton Capital LLC reported a 9.99% stake in Enveric Biosciences, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 13, 2025
Ayrton Capital LLC reported a 9.99% stake in Enveric Biosciences, Inc., 658,465 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 658,465
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ayrton Capital LLC | 9.99% | 658,465 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 9.99% | 658,465 |
| Waqas Khatri | 9.99% | 658,465 |
Source
Related
- Enveric Biosciences, Inc.
- Ayrton Capital LLC
- Enveric Biosciences, Inc. shareholders
- Schedule 13G/A · Ayrton Capital LLC · Aug 13, 2026
- Schedule 13G/A · Lind Global Fund III LP · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Coveney Kevin Michael · Jun 3, 2026
- Form 4 · Tucker Joseph Edward · Jun 3, 2026
- Form 4 · Pasqualone Frank · Jun 3, 2026